tetrahydrocannabinol/アサ属

BRIEF DESCRIPTION OF INVENTION This invention is directed to new compounds and compositions that are particularly and uniquely useful as internal standards in the analysis of tetrahydrocannabinol and its metabolites in biological fluids. These new standards have essentially the same partitioning,

CROSS REFERENCE TO RELATED APPLICATION This application is a national stage of PCT/EP01/11967 filed Oct. 16, 2001 and based upon DE 100 51 427.8 filed Oct. 17, 2000 under the International Convention. BACKGROUND OF THE INVENTION Field of the Invention The present invention relates to a process for

FIELD OF THE INVENTION This invention relates to compositions and methods for relieving pain using cannabinoids and cobalamin. The invention is especially useful for relieving pain in patients with psoriatic arthritis, fibromyalgia, scleroderma, shingles and related pain generating

TECHNICAL FIELD The present disclosure relates to improvements to cannabis farming systems and methods. The present disclosure also relates to a new and distinct plant named Grass Weedly Junior characterized by a hybrid between Cannabis sativa L. ssp. Sativa and Cannabis sativa L. ssp. Indica (Lam.)

The present invention relates to a plant extract from a low-tetrahydrocannabinol (THC) variety of Cannabis sativa subspecies sativa for the treatment of disease. Furthermore, the invention relates to the production of the extract and pharmaceutical or topical compositions, which contain this

The present invention relates to a plant extract from a low-tetrahydrocannabinol (THC) variety of Cannabis sativa subspecies sativa for the treatment of disease. Furthermore, the invention relates to the production of the extract and pharmaceutical or topical compositions, which contain this

BACKGROUND OF THE INVENTION 1. Field of the Invention This invention relates generally to topical analgesic and anti-inflammation agents and more particularly to the use of a rapid-onset cannabinoid delivery topical liniment for the relief of pain and reduction in inflammation associated with such

RELATED APPLICATIONS This application is a national stage filing under 35 U.S.C. .sctn.371 of international application PCT/GB2009/050621, filed Jun. 4, 2009, which was published under PCT Article 21(2) in English. The present invention relates to the use of a combination of cannabinoids in the

FIELD OF THE INVENTION This invention relates to topical formulations that comprise a Cannabis derived botanical drug product, methods of making the topical formulations, and methods of using the topical formulations in treating dermatological diseases. BACKGROUND OF THE INVENTION The botanical

FIELD OF THE INVENTION This invention relates to topical formulations that comprise a Cannabis derived botanical drug product, methods of making the topical formulations, and methods of using the topical formulations in treating dermatological diseases. BACKGROUND OF THE INVENTION The botanical

FIELD OF THE INVENTION This invention relates to topical formulations that comprise a Cannabis derived botanical drug product, methods of making the topical formulations, and methods of using the topical formulations in treating dermatological diseases. BACKGROUND OF THE INVENTION The botanical

STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT Not applicable. BACKGROUND OF THE INVENTION 1. Field of the Invention The field of the present invention relates to the detection of controlled substances, and in particular to the detection of a metabolite of

CROSS-REFERENCE TO RELATED APPLICATIONS Not Applicable. STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT Not applicable. BACKGROUND OF THE INVENTION 1. Field of the Invention The field of the present invention relates to the detection of controlled substances, and in particular to the

STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT Not applicable. BACKGROUND OF THE INVENTION 1. Field of the Invention The field of the present invention relates to the detection of controlled substances, and in particular to the detection of a metabolite of

FIELD OF THE INVENTION The present invention relates to a family of novel non-psychotropic cannabinoids, and to pharmaceutical compositions containing them, which are useful for preventing or alleviating neurotoxicity and inflammation. Said pharmaceutical compositions comprise as their active